The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call
1 Cash-Producing Stock on Our Watchlist and 2 We Question
10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument...
Why 10x Genomics (TXG) Stock Is Down Today
TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand
10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops
Barchart Research What to Expect from TXG Earnings TXG Generated May 6, 2026 Current Price $22.74 EPS Estimate $$-0.27 Consensus Rating Moderate Buy Average Move 5.49% TXG's Profit Timeline Keeps Stretching...
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
PLEASANTON, Calif. , April 29, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate...